Skip to main content
. 2020 Jul 3;35(Suppl 2):100. doi: 10.11604/pamj.supp.2020.35.24611

Table 1.

Initial laboratory results of the cases

Haematological Parameters Patient 1 Patient 2 Patient 3
White blood cell count (4.0 -11* 109/L 10.51 10.85 12.95
Neutrophils Absolute count (1.7-5.38) 9.22 7.77 10.60
Lymphocytes Absolute count (20.0-40.0) 0.67 18.2 1.68
Platelet count (150-450* 109/L) 406 177 349
Hemoglobin (14.0-17.5 g/dL) 12.8 15.5 10.9
Creatinine (59-104 umol/l) 242.11 128.76 136.78
BUN (2.76-8.07 mmol/l) 26.16 11.15 11.73
Prothrombin Time (control 11.8 seconds) 12.2 18.9 N/A
Activated partial thromboplastin (control 23.2 seconds) 23.2 24.3 N/A
D- Dimer (0-0.5 ug/ml) 7.3 6.52 6.20
Ferritin (22-322 ug/l) 1024 463 2601
Lactate Dehydrogenase (135-225 IU/L) 414 848 528.42
C- Reactive Protein serum (0.5-5 mg/L) 153 91.98 312
Procalcitonin 0.89 0.76 >100
Glycated hemoglobin (HB1Ac) 11.40% N/A 10.24%
Total cholesterol (mmol/l) 3.39 5.50 2.69
Triglycerides (mmol/l) 1.60 1.27 2.45
HDL (>1.68 mmol/l No risk, 1.15-1.68 moderate risk, <1.15 high risk) 0.78 0.80 0.46
LDL (<optimal >2.59 mmol/l, Borderline 2.59 -3.34, Borderline high 3.37-4.12, high > 4.14) 1.88 4.22 1.12
VLDL 0.73 0.58 1.11